FDA Approves Eli Lilly COVID-19 Drug Without Remdesivir

FDA Approves Eli Lilly COVID-19 Drug Without Remdesivir

Expanding on their emergency authorization from November, the FDA has granted Eli Lilly approval for the use of their COVID-19 drug baricitinib to be taken on its own and not in combination with Gilead’s drug remdesivir for patients with COVID-19. With the...